Effect of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Omeprazole Plasma Pharmacokinetics in Healthy Adults

por Braeckman, Rene A., Stirtan, William G., Soni, Paresh N.
Publicado 2014

Effect of Concomitant Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on the Pharmacokinetics of Atorvastatin

por Braeckman, Rene A., Stirtan, William G., Soni, Paresh N.
Publicado 2014

Pharmacokinetics of Eicosapentaenoic Acid in Plasma and Red Blood Cells After Multiple Oral Dosing With Icosapent Ethyl in Healthy Subjects

por Braeckman, Rene A, Stirtan, William G, Soni, Paresh N
Publicado 2014

Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Pharmacokinetic Parameters of Rosiglitazone in Healthy Subjects

por Braeckman, Rene A, Stirtan, William G, Soni, Paresh N
Publicado 2015

Icosapent Ethyl, a Pure Ethyl Ester of Eicosapentaenoic Acid: Effects on Circulating Markers of Inflammation from the MARINE and ANCHOR Studies

por Bays, Harold E., Ballantyne, Christie M., Braeckman, Rene A., Stirtan, William G., Soni, Paresh N.
Publicado 2013

Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200–500 mg/dL), and on statin therapy at LDL-...

por Brinton, Eliot A, Ballantyne, Christie M, Bays, Harold E, Kastelein, John J, Braeckman, Rene A, Soni, Paresh N
Publicado 2013

Rationale and design of REDUCE‐IT: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial

por Bhatt, Deepak L., Steg, Ph. Gabriel, Brinton, Eliot A., Jacobson, Terry A., Miller, Michael, Tardif, Jean‐Claude, Ketchum, Steven B., Doyle, Ralph T., Murphy, Sabina A., Soni, Paresh N., Braeckman, Rene A., Juliano, Rebecca A., Ballantyne, Christie M.
Publicado 2017